Similar articles for PMID: 32796597

Year	Number of Results
2005	1
2007	3
2008	2
2009	1
2010	5
2011	4
2012	5
2013	3
2014	3
2015	8
2016	15
2017	9
2018	8
2019	12
2020	9
2021	5
2022	8
2023	7
2024	0

1

High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG).

Salmoiraghi S, Cavagna R, Zanghì P, Pavoni C, Michelato A, Buklijas K, Elidi L, Intermesoli T, Lussana F, Oldani E, Caprioli C, Stefanoni P, Gianfaldoni G, Audisio E, Terruzzi E, De Paoli L, Borlenghi E, Cavattoni I, Mattei D, Scattolin A, Tajana M, Ciceri F, Todisco E, Campiotti L, Corradini P, Fracchiolla N, Bassan R, Rambaldi A, Spinelli O. Salmoiraghi S, et al. Cancers (Basel). 2020 Aug 11;12(8):2242. doi: 10.3390/cancers12082242. Cancers (Basel). 2020. PMID: 32796597 Free PMC article.

2

Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns.

Guan W, Zhou L, Li Y, Yang E, Liu Y, Lv N, Fu L, Ding Y, Wang N, Fang N, Liu Q, Wang B, Li F, Zhang J, Wang M, Wang L, Jing Y, Li Y, Yu L. Guan W, et al. Exp Hematol Oncol. 2021 Apr 9;10(1):27. doi: 10.1186/s40164-021-00207-4. Exp Hematol Oncol. 2021. PMID: 33836835 Free PMC article.

3

DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.

Ahn JS, Kim HJ, Kim YK, Lee SS, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, Kim DD. Ahn JS, et al. Biol Blood Marrow Transplant. 2016 Jan;22(1):61-70. doi: 10.1016/j.bbmt.2015.07.030. Epub 2015 Jul 31. Biol Blood Marrow Transplant. 2016. PMID: 26234722 Free article. Clinical Trial.

4

Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis.

Huang Y, Hu J, Lu T, Luo Y, Shi J, Wu W, Han X, Zheng W, He J, Cai Z, Wei G, Huang H, Sun J. Huang Y, et al. Cancer Manag Res. 2019 May 8;11:4129-4142. doi: 10.2147/CMAR.S194523. eCollection 2019. Cancer Manag Res. 2019. PMID: 31190985 Free PMC article.

5

Molecular genetic and clinical characterization of acute myeloid leukemia with trisomy 8 as the sole chromosome abnormality.

Liu J, Han W, Cai X, Wang Z, Cao L, Hua H, Jia Z, Chao H, Lu X, Shen H. Liu J, et al. Hematology. 2022 Dec;27(1):565-574. doi: 10.1080/16078454.2022.2071799. Hematology. 2022. PMID: 35549661

6

[The Mutated Gene Sequenced by NGS and the Correlation of Their Coexistent Mutual Exclusiveness in NPM1 Mutated Acute Myeloid Leukemia].

Dai L, Wang ZL, Qiu GQ, Wu YC, Zhang XW, Xing SS, Wang B. Dai L, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Dec;29(6):1733-1740. doi: 10.19746/j.cnki.issn.1009-2137.2021.06.007. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021. PMID: 34893102 Chinese.

7

Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.

Shamaa S, Laimon N, Aladle DA, Azmy E, Elghannam DM, Salem DA, Taalab MM. Shamaa S, et al. Hematology. 2014 Jan;19(1):22-30. doi: 10.1179/1607845413Y.0000000085. Epub 2013 Nov 25. Hematology. 2014. PMID: 23540998

8

Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.

Wang K, Zhou F, Cai X, Chao H, Zhang R, Chen S. Wang K, et al. Hematology. 2020 Dec;25(1):211-218. doi: 10.1080/16078454.2020.1765561. Hematology. 2020. PMID: 32476595

9

Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.

Ahn JS, Kim HJ, Kim YK, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, Kim DD. Ahn JS, et al. Ann Hematol. 2016 Mar;95(4):625-35. doi: 10.1007/s00277-015-2580-z. Epub 2015 Dec 22. Ann Hematol. 2016. PMID: 26692090

10

[Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].

Zhao CX, Wang JM, Li JM, Zou SH, Chen FY, Liang AB, Hou J, Hu XX, Zhang YX, Gu SY, Zhu JY, Li P, Du J, Yang YN, Qin YW, Wang XR, Wang C. Zhao CX, et al. Zhonghua Yi Xue Za Zhi. 2019 Oct 29;99(40):3145-3151. doi: 10.3760/cma.j.issn.0376-2491.2019.40.005. Zhonghua Yi Xue Za Zhi. 2019. PMID: 31694105 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year